Dechra Veterinary Products has launched an apple-flavoured presentation of Equipalazone (phenylbutazone), its NSAID for horses and ponies. 

Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis as well as to reduce post-surgical soft tissue reaction.   

The new apple-flavoured version, which contains no added sugar, is presented in 1.5g sachets which are added to feed. The existing unflavoured product is still available as Equipalazone Original.

Dechra Brand Manager Emma Jennings said: “The new apple flavoured Equipalazone is the same tried and trusted popular product that vets have been using for many years but the enhanced apple flavour should improve compliance amongst even the fussiest of feeders. 

"Equipalazone has been a best-selling treatment delivering powerful pain relief since we brought it to the market as the first microencapsulated phenylbutazone more than 45 years ago. The new apple flavoured presentation will give vets even more choice when it comes to providing pain relief and anti-inflammatory treatment for equine conditions."

For more information visit www.dechra.co.uk. 

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.